Results 141 to 150 of about 179,934 (163)

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma

EBioMedicine, 2020
Yi-Long Wu, Yi-Long Wu, Hao Sun
exaly  

TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines

Trends in Cancer, 2020
James G Jackson, Ashkan Shahbandi
exaly  

Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53

Cells, 2022
Alberto M Martelli, Przemysław Duda, James A. McCubrey   +2 more
exaly  

TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data

Human Mutation, 2016
Dmitriy Sonkin, Magali Olivier, Jiří Zavadil   +2 more
exaly  

TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome Free

Blood, 2012
Konstanze Döhner, Gerhard Held, Richard F Schlenk   +2 more
exaly  

Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients

Annals of Oncology, 2013
Isabella Sperduti, Giulia Fontemaggi, Federica Ganci   +2 more
exaly  

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study

Annals of Oncology, 2006
Thierry Soussi, Suet-yi Leung, Richie Soong   +2 more
exaly